Clinical Trial Update: Safety And Efficacy Of Rifabutin In HIV Patients

View source ↗

Summary

Clinical trial update on safety and efficacy of rifabutin in HIV patients with mycobacterial infections; results completed and posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disseminated Mycobacterium Avium Complex Disease Associated with HIV Infection
• Non-tuberculous Mycobacterial Diseases
• Tuberculosis

Drugs mentioned

• RIFABUTIN (Rifabutin)

Snippet

Sponsor: Pfizer | Conditions: Non-tuberculous Mycobacterial Diseases, Tuberculosis | Status: COMPLETED | Results posted: 2019-08-02